Oncology

  1. Impact of the COVID-19 Pandemic on Treatment Patterns for Patients With Metastatic Solid Cancer in the United States

    1. Ravi B Parikh
    2. Samuel U Takvorian
    3. Daniel Vader
    4. E Paul Wileyto
    5. Amy S Clark
    6. Daniel J Lee
    7. Gaurav Goyal
    8. Gabrielle B Rocque
    9. Efrat Dotan
    10. Daniel M Geynisman
    11. Pooja Phull
    12. Philippe E Spiess
    13. Roger Y Kim
    14. Amy J Davidoff
    15. Cary P Gross
    16. Natalia Neparidze
    17. Rebecca A Miksad
    18. Gregory S Calip
    19. Caleb M Hearn
    20. Will Ferrell
    21. Lawrence N Shulman
    22. Ronac Mamtani
    23. Rebecca A Hubbard
    24. the PRACTICE Investigators

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. High seroconversion rates amongst black and Hispanics with hematologic malignancies after SARS-CoV-2 vaccination

    1. Lauren C. Shapiro
    2. Astha Thakkar
    3. Radhika Gali
    4. Jesus D. Gonzalez-Lugo
    5. Abdul-Hamid Bazarbachi
    6. Shafia Rahman
    7. Kith Pradhan
    8. Karen Fehn
    9. Michelly Abreu
    10. Noah Kornblum
    11. Kira Gritsman
    12. Mendel Goldfinger
    13. Aditi Shastri
    14. Ioannis Mantzaris
    15. Ira Braunschweig
    16. Balazs Halmos
    17. Amit Verma
    18. Margaret McCort
    19. Lizamarie Bachier-Rodriguez
    20. R. Alejandro Sica

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. COVID ‐19 outcomes in patients with cancer: Findings from the University of California health system database

    1. Daniel H. Kwon
    2. Jose Cadena
    3. Sam Nguyen
    4. Kwan Ho Ryan Chan
    5. Braden Soper
    6. Amy L. Gryshuk
    7. Julian C. Hong
    8. Priyadip Ray
    9. Franklin W. Huang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients with Malignancy

    1. Mona Ariamanesh
    2. Pejman Porouhan
    3. Babak PeyroShabany
    4. Danial Fazilat-Panah
    5. Mansoureh Dehghani
    6. Maryam Nabavifard
    7. Farbod Hatami
    8. Mohammad Fereidouni
    9. James S. Welsh
    10. Seyed Alireza Javadinia

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Predicted long‐term impact of COVID ‐19 pandemic‐related care delays on cancer mortality in Canada

    1. Talía Malagón
    2. Jean H. E. Yong
    3. Parker Tope
    4. Wilson H. Miller
    5. Eduardo L. Franco
    6. McGill Task Force on the Impact of COVID‐19 on Cancer Control and Care

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Efficacy of Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine in Patients With Thoracic Cancer: A Prospective Study Supporting a Third Dose in Patients With Minimal Serologic Response After Two Vaccine Doses

    1. Valérie Gounant
    2. Valentine Marie Ferré
    3. Ghassen Soussi
    4. Charlotte Charpentier
    5. Héloïse Flament
    6. Nadhira Fidouh
    7. Gilles Collin
    8. Céline Namour
    9. Sandra Assoun
    10. Alexandra Bizot
    11. Zohra Brouk
    12. Eric Vicaut
    13. Luis Teixeira
    14. Diane Descamps
    15. Gérard Zalcman

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Mutation analysis links angioimmunoblastic T-cell lymphoma to clonal hematopoiesis and smoking

    1. Shuhua Cheng
    2. Wei Zhang
    3. Giorgio Inghirami
    4. Wayne Tam

    • Curated by eLife

      Evaluation Summary:

      This paper provides supportive sequencing data for the hypothesis of association between AITL and pre-existing clonal hematopoiesis. It will be of interest to researchers in both lymphoma and myeloid malignancies and raises new hypotheses about the potential smoking-related mechanisms (C>A signature) that may contribute to development of AITL in the background of clonal hematopoiesis. The hypotheses need further validation, as the authors used a small sample and make indirect inferences about the origin of the observed mutations.

      (This preprint has been reviewed by eLife. We include the public reviews from the reviewers here; the authors also receive private feedback with suggested changes to the manuscript. Reviewer #1 and Reviewer #2 agreed to share their names with the authors.)

    Reviewed by eLife

    4 evaluationsAppears in 1 listLatest version Latest activity

  8. Negative Impact of COVID-19 Associated Health System Shutdown on Patients Diagnosed With Colorectal Cancer: A Retrospective Study From a Large Tertiary Center in Ontario, Canada

    1. Catherine L Forse
    2. Stephanie Petkiewicz
    3. Iris Teo
    4. Bibianna Purgina
    5. Kristina-Ana Klaric
    6. Tim Ramsay
    7. Jason K Wasserman

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Intentions to participate in cervical and colorectal cancer screening during the COVID-19 pandemic: A mixed-methods study

    1. Rebecca Wilson
    2. Harriet Quinn-Scoggins
    3. Yvonne Moriarty
    4. Jacqueline Hughes
    5. Mark Goddard
    6. Rebecca Cannings-John
    7. Victoria Whitelock
    8. Katriina L. Whitaker
    9. Detelina Grozeva
    10. Julia Townson
    11. Kirstie Osborne
    12. Stephanie Smits
    13. Michael Robling
    14. Julie Hepburn
    15. Graham Moore
    16. Ardiana Gjini
    17. Kate Brain
    18. Jo Waller

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Possibility of SARS-CoV-2 Infection in the Metastatic Microenvironment of Cancer

    1. Takuma Hayashi
    2. Kenji Sano
    3. Ikuo Konishi

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 7 of 10 Next